Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial

T. H. Brannagan, A. K. Wang, T. Coelho, M. Waddington Cruz, M. J. Polydefkis, P. J. Dyck, V. Plante-Bordeneuve, J. L. Berk, F. Barroso, G. Merlini, I. Conceição, S. G. Hughes, J. Kwoh, S. W. Jung, S. Guthrie, M. Pollock, M. D. Benson, M. Gertz, Brian Drachman, Peter GorevicStephen Heitner, Morton Scheinberg, Hartmut Schmidt, Carol Whelan, David Adams, Josep Maria Campistol Plana, Josep Gamez, Edward Gane, Arnt Kristen, Laura Obici, Fabrizio Salvi, Acary Souza Bulle Oliveira, Giuseppe Vita

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial'. Together they form a unique fingerprint.

Medicine & Life Sciences